相关实验视频
早期,有限的Mycobacterium ulcerans感染的抗菌治疗:一个随机对照试验
Willemien A Nienhuis1, Ymkje Stienstra, William A Thompson
1Department of Internal Medicine, University Medical Centre Groningen, University of Groningen, Netherlands.
Lancet (London, England)
|February 9, 2010
概括
抗菌治疗有效地治愈了早期的布鲁利病. 一个为期4周的链杆菌素和利芬皮辛治疗方案,其次是清红素,显示了与链杆菌素和利芬皮辛治疗8周的疗效相似,减少了注射量.
科学领域:
- 传染性疾病 传染性疾病
- 热带医学 热带医学
- 皮肤病学 皮肤病学
背景情况:
- 手术除菌是Mycobacterium ulcerans感染 (布鲁利病) 的标准.
- 2004年世卫组织的指导方针建议在外科手术的同时进行抗菌药物治疗 (链杆菌素和利番素).
- 以前的证据包括观察性研究和一项小型试点研究.
研究的目的:
- 为了研究两种抗微生物治疗方案对早期Mycobacterium ulcerans感染的疗效.
- 为了比较一个4周的链胺基治疗方案和一个更长的8周的治疗方案.
主要方法:
- 一个平行的,开放的,随机的试验在加纳进行.
- 用PCR确认的早期,有限的M. ulcerans感染的患者被纳入.
- 两组接受了不同持续时间的链杆菌素和利方皮素,其中一组转换为澄菌素.
主要成果:
- 经过1年后的损伤愈合观察到96%的8周 estreptomycin 组和91%的4周 estreptomycin 加上明素组.
- 没有参与者在1年后出现病变复发.
- 不良事件包括静脉毒性事件和注射,在4周的克拉里斯罗米辛组的发病率略高.
结论:
- 抗菌治疗对于早期的,有限的M. ulcerans感染是有效的.
- 一个为期4周的思列托米辛/里法辛治疗方案,其次是澄胺,与8周的思列托米辛/里法辛治疗方案同样有效.
- 在4周后切换为口服克拉里思罗米辛,可以减少注射链杆菌素的次数.
相关概念视频
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...